Related Experiment Video
Updated: Jan 20, 2026
COVID-19 / Coronavirus Outbreak: How to Perform a Bronchoscopy
Published on: May 13, 2020
HIV Status and COVID-19 Treatment Disparities in the US National Clinical Cohort Collaborative
Emmanuel Nazaire Essam Nkodo1, Pooja Maheria2, Eric Hurwitz3
1Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Insights
People with HIV had better access to COVID-19 therapeutics, but racial and ethnic disparities in treatment were still observed. This highlights ongoing inequities in care despite higher overall access for this group.
Area of Science:
- Infectious Diseases
- Public Health
- Health Equity
Background:
- COVID-19 therapeutic access disparities are known.
- The impact of HIV status on treatment access and its intersection with sociodemographics is under-explored.
Purpose of the Study:
- To investigate disparities in COVID-19 therapeutic prescription among persons with and without HIV.
- To analyze how HIV status intersects with sociodemographic factors in accessing COVID-19 treatments.
Main Methods:
- Retrospective cohort study using data from January 2020 to November 2024.
- Included 7,806,412 patients with COVID-19, of whom 45,508 (0.58%) had HIV.
- Logistic and linear regression models were used to assess treatment receipt associations.
Main Results:
- Persons with HIV had higher odds of receiving remdesivir (aOR 1.26) and nirmatrelvir/ritonavir (aOR 2.86) compared to those without HIV.
- Significant racial/ethnic inequities were observed, with American Indian/Alaskan Native and Hispanic/Latinx persons with HIV showing lower remdesivir receipt.
- Black/African American, American Indian/Alaskan Native, and Hispanic/Latinx individuals (with and without HIV) had lower nirmatrelvir/ritonavir receipt compared to White counterparts.
Conclusions:
- Persons with HIV had increased odds of receiving COVID-19 therapeutics.
- Persistent racial and ethnic inequities in treatment uptake were evident despite higher overall access for persons with HIV.
Background:
While disparities in COVID-19 therapeutic access have been documented, the effect of HIV status on treatment access and how it intersects with other sociodemographic factors has not been well explored. Using data from the National Clinical Cohort Collaborative (N3C), we investigated disparities in COVID-19 therapeutic prescription among persons with HIV and without HIV.
Methods:
This was a retrospective cohort study of patients' data from January 2020 to November 2024. The study included 7 806 412 patients with a COVID-19 diagnosis, of whom 45 508 (0.58%) were persons with HIV. We employed logistic and linear regression models to assess associations between therapeutic receipt and patient characteristics.
Results:
Persons with HIV had significantly higher adjusted odds of receiving COVID-19 therapeutics compared to persons without HIV (remdesivir, aOR 1.26 [95% CI: 1.20, 1.33]; nirmatrelvir/ritonavir, aOR 2.86 [95% CI: 2.77, 2.95]). Despite this, significant racial/ethnic inequities were observed. American Indian or Alaskan Native persons with HIV (estimated coefficient 0.997) and Hispanic/Latinx persons with HIV (estimated coefficient 0.992) had a lower estimated prevalence of remdesivir receipt compared to White Non-Hispanic individuals. For nirmatrelvir/ritonavir, Black/African American individuals (persons with HIV, estimated coefficient 0.947; persons without HIV, estimated coefficient 0.943), American Indian or Alaskan Native persons with HIV (estimated coefficient 0.996), and Hispanic/Latinx individuals (estimated coefficient 0.992) showed a lower estimated prevalence of receipt compared to their White counterparts.
Conclusions:
Persons with HIV demonstrated higher odds of receiving COVID-19 therapeutics than persons without HIV. However, persistent racial and ethnic inequities in treatment uptake were evident.
Related Concept Videos
COVID-19 / Coronavirus Outbreak: How To Perform A Bronchoscopy
08:15Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
COVID-19 / Coronavirus Outbreak: How to perform complete prone positioning in COVID-Patients
COVID-19 / Coronavirus Outbreak: How to take blood cultures
COVID-19 / Coronavirus Outbreak: Protecting The Airway - Endotracheal Intubation
COVID-19 / Coronavirus Outbreak: Donning Personal Protective Equipment Before Entering A Patient Room
